Vesteck is an early-stage medical device company based in West Chester, Pa., led by CEO Joe Rafferty and CMO Dr. David H. Deaton. The company has designed a platform comprised of six devices that integrate delivery of nitinol sutures into a catheter to improve clinical outcomes for endovascular aortic aneurysm patients. Its first product, the “Suture-Tight” nitinol suture delivery catheter, targets the endovascular aortic repair market. Vesteck intends to serve the aortic repair, structural heart, and GI markets with its proprietary technology. The company plans to use newly raised funds to support manufacturing, pre-clinical testing, and completion of in-human procedures. These steps are intended to precede a clinical study aimed at FDA clearance.

Total raised

$6M

Funding rounds

1

Latest round

Series A

Latest activity

Jan 2022